Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

Views of the New Medicare Drug Law: A Survey of People On Medicare
Kaiser Family Foundation/Harvard School of Public Health, 8-1-04

The Kaiser Family Foundation and the Harvard School of Public Health have released a survey of American seniors on Medicare that finds that nearly twice as many respondents have an unfavorable view of the new Medicare law as have a favorable view. The survey is undoubtedly true - although perhaps not really relevant. The main reform under the law, the Medicare prescription drug benefit, wonít take effect until 2006. Other recently released studies have found that the drug discount card program in place till then is offering seniors significant savings, especially low-income seniors, who receive a $600 subsidy.

The survey also noted that most respondents thought that the law would help low-income seniors, and seniors with very high prescription drug bills, although they didnít think it would help them personally. This seems to suggest that most seniors outside of these categories arenít paying much attention to the bill, and may very well have a different opinion of it in 2006.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000